You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API NORETHINDRONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing NORETHINDRONE ACETATE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
RPK Pharmaceuticals Inc MICROGESTIN 1/20 norethindrone acetate and ethinyl estradiol 53002-1549 ACACIA
RPK Pharmaceuticals Inc MICROGESTIN 1/20 norethindrone acetate and ethinyl estradiol 53002-1549 LACTOSE
RPK Pharmaceuticals Inc MICROGESTIN 1/20 norethindrone acetate and ethinyl estradiol 53002-1549 MAGNESIUM STEARATE
RPK Pharmaceuticals Inc MICROGESTIN 1/20 norethindrone acetate and ethinyl estradiol 53002-1549 STARCH, CORN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing NORETHINDRONE ACETATE

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc norethindrone acetate 0378-7291 ANHYDROUS LACTOSE
Mylan Pharmaceuticals Inc norethindrone acetate 0378-7291 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc norethindrone acetate 0378-7291 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc norethindrone acetate 0378-7291 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for NORETHINDRONE ACETATE

Excipient focus: .ALPHA.-TOCOPHEROL

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

Excipient focus: ACACIA

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

NORETHINDRONE ACETATE drug variants not containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Mylan Pharmaceuticals Inc norethindrone acetate and ethinyl estradiol 0378-7274
Mylan Pharmaceuticals Inc norethindrone acetate and ethinyl estradiol 0378-7280
Teva Pharmaceuticals USA Inc norethindrone acetate and ethinyl estradiol 0555-9025
A-S Medication Solutions norethindrone acetate and ethinyl estradiol 50090-6782
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C RED NO. 30

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

NORETHINDRONE ACETATE drug variants not containing MAGNESIUM STEARATE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc norethindrone acetate and ethinyl estradiol 0093-3122
Physicians Total Care Inc norethindrone acetate and ethinyl estradiol 54868-6251
Lupin Pharmaceuticals Inc norethindrone acetate and ethinyl estradiol 68180-827
Glenmark Pharmaceuticals Inc USA norethindrone acetate and ethinyl estradiol 68462-656
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: MALTODEXTRIN

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TOCOPHEROL

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group